GSK plc (GLAXF)
OTCMKTS · Delayed Price · Currency is USD
27.23
0.00 (0.00%)
Mar 9, 2026, 9:30 AM EST
GSK plc Market Cap
GSK plc has a market cap or net worth of $111.26 billion as of March 10, 2026. Its market cap has increased by 46.45% in one year.
Market Cap
111.26B
Enterprise Value
130.02B
Revenue
43.97B
Ranking
n/a
PE Ratio
14.46
Stock Price
$27.23
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has increased from 96.45B to 111.26B, an increase of 15.35%. That is a compound annual growth rate of 0.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 111.26B | 12.93% |
| Dec 31, 2025 | 98.52B | 43.23% |
| Dec 31, 2024 | 68.79B | -8.64% |
| Dec 29, 2023 | 75.29B | 7.04% |
| Dec 30, 2022 | 70.34B | -35.43% |
| Dec 31, 2021 | 108.95B | 19.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 791.42M |
| Veradigm | 724.25M |
| Glass House Brands | 718.57M |
| Elite Pharmaceuticals | 429.68M |
| American Oncology Network | 360.64M |
| Northwest Biotherapeutics | 360.57M |
| CytoDyn | 296.04M |
| Silence Therapeutics | 294.27M |